North America Sciatica Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Drug Class (Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others), By Country and Growth Forecast, 2022

List of Tables

The North America Sciatica Treatment Market would witness market growth of 2.4% CAGR during the forecast period (2022-2028).

Sciatica pain radiates from the lumbar region of the body (lower back) to the back of the thigh. However, it might extend below the knee as well. The biggest nerve in the human body is the sciatic nerve. The sciatic nerve originates from the lumbar spinal cord's nerve roots in the lower back region and extends across the buttock region, directing nerve terminals to the lower limb. A lumbar disc herniation is a common cause of sciatica because it presses directly on the nerve. Sciatica symptoms may be brought on by any factor that inflames or irritates the sciatic nerve.

Radiculopathy is a word used to describe abnormalities in the intervertebral disc caused by nerve irritation. Other causes of sciatica pain, besides a stretched nerve from a disc, include injury, internal bleeding, infections in or around the lumbar spine, muscle, tumors, and nerve irritation from nearby bone. The inflammation of the sciatic nerve may sometimes produce sciatica pain during pregnancy. Several risk factors accompany the discomfort in the sciatic nerve. They include lumbar spine trauma, slipped discs, lumbar disc disease, and degenerative arthritis.

The number of Americans 65 and over increased from 40.3 million in the 2010 Census to 54.1 million in the population estimates as of July 1, 2019, according to the US Census Bureau. Those who are older are more susceptible to illnesses like sciatica. The North American region is anticipated to occupy a significant share of the sciatica market over the forecast period. The United States is one of the most affected countries in the world due to the relatively high numbers of patients struggling with sciatica and higher in the North American geographical area as the patient population is rising compared to other countries.

The US market dominated the North America Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $215,115.4 Thousands by 2028. The Canada market is poised to grow at a CAGR of 4.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 3.8% during (2022 - 2028).

Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)

Scope of the Study

Market Segments covered in the Report:

By Type

Chronic
Acute
Others

By Distribution Channel

Retail & Specialty Pharmacies
Hospital Pharmacies
Online Providers

By Drug Class

Non-Steroidal anti-inflammatory
Steroids
Antidepressants
Others

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Abbott Laboratories
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Sorrento Therapeutics, Inc.
Alkem Laboratories Ltd.
Amneal Pharmaceuticals, Inc.
Aurobindo Pharma Limited
Novartis AG
Cadila Healthcare Ltd. (Zydus Cadila)

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Sciatica Treatment Market, by Type
- 1.4.2 North America Sciatica Treatment Market, by Distribution Channel
- 1.4.3 North America Sciatica Treatment Market, by Drug Class
- 1.4.4 North America Sciatica Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. North America Sciatica Treatment Market by Type

3.1 North America Chronic Market by Country
3.2 North America Acute Market by Country
3.3 North America Others Market by Country

Chapter 4. North America Sciatica Treatment Market by Distribution Channel

4.1 North America Retail & Specialty Pharmacies Market by Country
4.2 North America Hospital Pharmacies Market by Country
4.3 North America Online Providers Market by Country

Chapter 5. North America Sciatica Treatment Market by Drug Class

5.1 North America Non-Steroidal anti-inflammatory Market by Country
5.2 North America Steroids Market by Country
5.3 North America Antidepressants Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Sciatica Treatment Market by Country

6.1 US Sciatica Treatment Market
- 6.1.1 US Sciatica Treatment Market by Type
- 6.1.2 US Sciatica Treatment Market by Distribution Channel
- 6.1.3 US Sciatica Treatment Market by Drug Class
6.2 Canada Sciatica Treatment Market
- 6.2.1 Canada Sciatica Treatment Market by Type
- 6.2.2 Canada Sciatica Treatment Market by Distribution Channel
- 6.2.3 Canada Sciatica Treatment Market by Drug Class
6.3 Mexico Sciatica Treatment Market
- 6.3.1 Mexico Sciatica Treatment Market by Type
- 6.3.2 Mexico Sciatica Treatment Market by Distribution Channel
- 6.3.3 Mexico Sciatica Treatment Market by Drug Class
6.4 Rest of North America Sciatica Treatment Market
- 6.4.1 Rest of North America Sciatica Treatment Market by Type
- 6.4.2 Rest of North America Sciatica Treatment Market by Distribution Channel
- 6.4.3 Rest of North America Sciatica Treatment Market by Drug Class

Chapter 7. Company Profiles

7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
7.2 Johnson & Johnson
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental &Regional Analysis
- 7.2.4 Research & Development Expenses
7.3 Teva Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expenses
7.4 Sun Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional & Segmental Analysis
- 7.4.4 Research & Development Expenses
7.5 Sorrento Therapeutics, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental Analysis
- 7.5.4 Research & Development Expenses
7.6 Alkem Laboratories Ltd.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Amneal Pharmaceuticals, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental
- 7.7.4 Research & Development Expenses
7.8 Aurobindo Pharma Limited
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expense
7.9 Novartis AG
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
7.10. Cadila Healthcare Ltd. (Zydus Cadila)
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expense

LIST OF TABLES

TABLE 1 North America Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 2 North America Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 3 North America Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 4 North America Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 5 North America Chronic Market by Country, 2018 - 2021, USD Thousands
TABLE 6 North America Chronic Market by Country, 2022 - 2028, USD Thousands
TABLE 7 North America Acute Market by Country, 2018 - 2021, USD Thousands
TABLE 8 North America Acute Market by Country, 2022 - 2028, USD Thousands
TABLE 9 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 10 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 11 North America Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 12 North America Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 13 North America Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Thousands
TABLE 14 North America Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Thousands
TABLE 15 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Thousands
TABLE 16 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Thousands
TABLE 17 North America Online Providers Market by Country, 2018 - 2021, USD Thousands
TABLE 18 North America Online Providers Market by Country, 2022 - 2028, USD Thousands
TABLE 19 North America Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 20 North America Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 21 North America Non-Steroidal anti-inflammatory Market by Country, 2018 - 2021, USD Thousands
TABLE 22 North America Non-Steroidal anti-inflammatory Market by Country, 2022 - 2028, USD Thousands
TABLE 23 North America Steroids Market by Country, 2018 - 2021, USD Thousands
TABLE 24 North America Steroids Market by Country, 2022 - 2028, USD Thousands
TABLE 25 North America Antidepressants Market by Country, 2018 - 2021, USD Thousands
TABLE 26 North America Antidepressants Market by Country, 2022 - 2028, USD Thousands
TABLE 27 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 28 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 29 North America Sciatica Treatment Market by Country, 2018 - 2021, USD Thousands
TABLE 30 North America Sciatica Treatment Market by Country, 2022 - 2028, USD Thousands
TABLE 31 US Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 32 US Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 33 US Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 34 US Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 35 US Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 36 US Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 37 US Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 38 US Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 39 Canada Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 40 Canada Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 41 Canada Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 42 Canada Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 43 Canada Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 44 Canada Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 45 Canada Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 46 Canada Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 47 Mexico Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 48 Mexico Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 49 Mexico Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 50 Mexico Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 51 Mexico Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 52 Mexico Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 53 Mexico Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 54 Mexico Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 55 Rest of North America Sciatica Treatment Market, 2018 - 2021, USD Thousands
TABLE 56 Rest of North America Sciatica Treatment Market, 2022 - 2028, USD Thousands
TABLE 57 Rest of North America Sciatica Treatment Market by Type, 2018 - 2021, USD Thousands
TABLE 58 Rest of North America Sciatica Treatment Market by Type, 2022 - 2028, USD Thousands
TABLE 59 Rest of North America Sciatica Treatment Market by Distribution Channel, 2018 - 2021, USD Thousands
TABLE 60 Rest of North America Sciatica Treatment Market by Distribution Channel, 2022 - 2028, USD Thousands
TABLE 61 Rest of North America Sciatica Treatment Market by Drug Class, 2018 - 2021, USD Thousands
TABLE 62 Rest of North America Sciatica Treatment Market by Drug Class, 2022 - 2028, USD Thousands
TABLE 63 Key Information - Abbott Laboratories
TABLE 64 Key information -Johnson & Johnson
TABLE 65 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 66 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 67 Key Information - Sorrento Therapeutics, Inc.
TABLE 68 Key Information - Alkem Laboratories Ltd.
TABLE 69 Key Information - Amneal Pharmaceuticals, Inc.
TABLE 70 key information - Aurobindo Pharma Limited
TABLE 71 Key Information - Novartis AG
TABLE 72 Key Information - Cadila Healthcare Ltd.

List of Figures

FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories

North America Sciatica Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Drug Class (Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others), By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents